Generic Xanax Recall Issued Due To Foreign Substance That May Cause Infections
Mylan is recalling one lot of generic Xanax which may be contaminated with a foreign substance, putting users at increased risk of infections.
Tag Archives: Mylan Pharmaceuticals
-
-
Mylan Valsartan Recall Expanded As More Lots Found To Be Contaminated With NDEA
A valsartan recall has been expanded to affect another 104 lots of Mylan products which may be contaminated with cancer-causing impurities.
-
Valsartan Recall Issued For Mylan Products Contaminated With NDEA
Mylan is recalling 15 lots of various valsartan-based products due to contamination by NDEA, a cancer-causing impurity.
-
EpiPen Problems Lead to Recall Expansion for Products Sold In U.S.
An EpiPen recall has been expanded to include injection devices sold in the U.S.
-
EpiPen Recall Issued Outside U.S., Due to Risk Emergency Allergy Drug May Not Work
A recall of more than 80,000 EpiPens in Europe and Asia was announced following reports that the devices failed to deliver medication when used.
-
Mylan Gets Warning Letter Over Cancer Drug Recalls
The FDA has issued a warning letter to Mylan over the conditions at three factories associated with recent cancer drug recalls.
-
FDA Probes Generic Toprol XL Effectiveness Following Complaints
The FDA is calling for new studies into generic Toprol following thousands of reports that they are not as safe or effective as the brand name drug.
-
Actos Risks Cause Consumer Reports To Urge Diabetics to Avoid Drug
A consumer watchdog group is urging diabetics to avoid using either Actos or the new generic equivalent that was recently approved, saying that the health risks associated with side effects…
-
Generic Actos Approved Amid Lawsuits Over Bladder Cancer Warnings
Despite growing concerns about the adequacy of warnings about the risk of bladder cancer from Actos side effects, the FDA approved the first generic version of the popular diabetes drug…
-
Watson Fentanyl Patch Lawsuits Consolidated in MDL
All federal fentanyl patch lawsuits filed against Watson Pharmaceuticals will be transferred to one judge for coordinated pre-trial proceedings, as part of an MDL, or multidistrict litigation.
